Physician
Tarabey, Reina
Tarabey, Reina was paid $974K by Medicaid between Feb 2018 and Nov 2024, across 96 billing codes. Its largest line is 0202U, Oncology (prostate), multianalyte, gene expression profiling — 64% of everything it billed.
33Billing provider infoTARABEY, REINA
CHICAGO, IL 60616
CHICAGO, IL 60616
33aNPI1053402206assigned 09/27/2006
33bProvider typeAnatomic Pathology Physician
28Total paid$974K
24GClaims46,107
24DCodes billed96
24AFirst – last monthFeb 2018 – Nov 2024
Compared with peers
Next to other Anatomic Pathology Physician providers in Illinois
Rank by total paid#6 of 38
Median peer was paid$56K
This provider vs. median17×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 445 | $7K | |
| 2019 | 794 | $15K | |
| 2020 | 4,464 | $383K | |
| 2021 | 39,526 | $535K | |
| 2022 | 221 | $10K | |
| 2023 | 359 | $12K | |
| 2024incomplete | 298 | $12K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 64% | 2,833 | 2,389 | $627K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 6.1% | 2,194 | 1,885 | $59K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.6% | 1,073 | 974 | $25K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.6% | 1,070 | 973 | $25K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.0% | 759 | 719 | $20K |
| 80053 | Comprehensive metabolic panel | 2.0% | 3,821 | 2,549 | $19K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.9% | 350 | 298 | $19K |
| 88307 | 1.9% | 511 | 460 | $18K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.4% | 616 | 460 | $14K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.4% | 437 | 388 | $13K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 3,517 | 2,286 | $10K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,081 | 954 | $9K |
84 more codes
| 87536 | <1% | 188 | $8K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,782 | $7K |
| 83735 | <1% | 1,742 | $6K | |
| 86780 | <1% | 620 | $5K | |
| 84484 | <1% | 1,246 | $5K | |
| 87186 | <1% | 600 | $4K | |
| 85027 | <1% | 1,399 | $4K | |
| 81025 | <1% | 1,705 | $4K | |
| 83880 | <1% | 334 | $3K | |
| 88312 | <1% | 281 | $3K | |
| 83655 | <1% | 489 | $3K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 200 | $3K |
| 83690 | <1% | 828 | $3K | |
| 81001 | <1% | 1,860 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 826 | $3K |
| 88342 | <1% | 133 | $2K | |
| 87040 | <1% | 211 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 297 | $2K |
| 83605 | <1% | 416 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 272 | $2K |
| 86480 | <1% | 70 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 331 | $2K |
| 84702 | <1% | 383 | $2K | |
| 80061 | Lipid panel | <1% | 921 | $2K |
| 84100 | <1% | 1,091 | $2K | |
| 86360 | <1% | 125 | $2K | |
| 84439 | <1% | 326 | $1K | |
| 87205 | <1% | 705 | $1K | |
| 85730 | <1% | 445 | $1K | |
| 86359 | <1% | 121 | $1K | |
| 86901 | <1% | 505 | $1K | |
| 87340 | <1% | 174 | $1K | |
| 82803 | <1% | 107 | $1K | |
| 85610 | <1% | 540 | $1K | |
| 87210 | <1% | 424 | $994.05 | |
| 85379 | <1% | 262 | $971.25 | |
| 82607 | <1% | 160 | $942.00 | |
| 86850 | <1% | 307 | $890.34 | |
| 86900 | <1% | 504 | $874.51 | |
| 80074 | <1% | 45 | $808.08 | |
| 87147 | <1% | 372 | $795.20 | |
| 87517 | <1% | 28 | $782.60 | |
| 87070 | <1% | 260 | $775.00 | |
| 80076 | <1% | 212 | $740.91 | |
| 86706 | <1% | 104 | $728.00 | |
| 82746 | <1% | 114 | $641.76 | |
| 86003 | <1% | 19 | $631.44 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 100 | $618.30 |
| 82728 | <1% | 155 | $594.14 | |
| 86803 | <1% | 71 | $589.40 | |
| 85007 | <1% | 362 | $575.75 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 59 | $519.20 |
| 86140 | <1% | 218 | $505.25 | |
| 82330 | <1% | 46 | $440.88 | |
| 83550 | <1% | 107 | $393.76 | |
| 83540 | <1% | 126 | $392.37 | |
| 82043 | <1% | 202 | $390.06 | |
| 84481 | <1% | 78 | $376.71 | |
| 82274 | <1% | 74 | $365.00 | |
| 85651 | <1% | 158 | $354.20 | |
| 85014 | <1% | 339 | $338.72 | |
| 85018 | <1% | 286 | $296.96 | |
| 86762 | <1% | 61 | $254.34 | |
| 82105 | <1% | 29 | $238.09 | |
| 87081 | <1% | 82 | $229.10 | |
| 81003 | <1% | 223 | $228.90 | |
| 84480 | <1% | 47 | $219.88 | |
| 82570 | <1% | 100 | $216.69 | |
| 86038 | <1% | 27 | $197.50 | |
| 86920 | <1% | 45 | $188.00 | |
| 85060 | <1% | 13 | $157.28 | |
| 83615 | <1% | 74 | $123.49 | |
| 86592 | <1% | 55 | $112.00 | |
| 82550 | <1% | 63 | $103.72 | |
| 87077 | <1% | 176 | $99.00 | |
| 84132 | <1% | 54 | $98.85 | |
| 87350 | <1% | 13 | $97.76 | |
| 84153 | <1% | 14 | $92.40 | |
| 84156 | <1% | 80 | $85.10 | |
| 83021 | <1% | 13 | $79.17 | |
| 84295 | <1% | 41 | $75.76 | |
| 84550 | <1% | 63 | $63.51 | |
| 82948 | <1% | 36 | $56.46 | |
| 84145 | <1% | 71 | $48.99 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.